Voltar à classificação

The Ensign Group, Inc. (ENSG)

NEUTRAL
HealthcareMedical Care FacilitiesUnited States

Fundamental

68

Preço

$178.44

Capitalização de Mercado

$10.57B

Parte 1 · Quanto vale a empresa

Visão Geral

The Ensign Group, Inc. provides skilled nursing, senior living, and rehabilitative services. It operates through two segments: Skilled Services and Standard Bearer. The Skilled Services segment provides short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; specialty care, such as on-site dialysis, ventilator care, cardiac, and pulmonary management; and standard services, such as room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. The Standard Bearer segment leases post-acute care properties to healthcare operators. In addition, the company operates senior living units; and provides ancillary services consisting of digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, and long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities, as well as mobile diagnostics. The company operates healthcare facilities in Alabama, Alaska, Arizona, Colorado, Idaho, Iowa, Kansas, Oregon, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington, and Wisconsin. The company was incorporated in 1999 and is based in San Juan Capistrano, California.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

Balanço & Liquidez

Receita

$5.46B

Últimos 12 meses (até 30/06/2026)

Resultado Líquido

$379M

Últimos 12 meses (até 30/06/2026)

Fluxo de Caixa Livre

-

Capital Próprio Total

$2.23B

Passivo Total

$3.23B

Rácio de Liquidez

1.21

Cobertura de Juros

59.99

Dívida/EBITDA

4.25

Resultados Por Ação

Receita & Resultado Líquido

Fluxo de Caixa Livre

Decomposição dos Resultados

Demonstração histórica

Margens ao longo do tempo

A dívida ao longo do tempo

Quanto pesa a dívida

Grelha do crescimento

Crescimento — Receitas

Estimativa de Valor Justo

Justamente Valorizada

Valor Justo

$154.78

Preço Atual

$178.44

Margem de Segurança

-15.3%

Intervalo de Valor Justo

$100.60 - $208.95

Métodos de Estimativa

Analyst Target:$220.00
DCF:$93.59
PE-based:$139.36
Graham Growth:$202.81
EPV:$75.66
Consenso dos Analistas:Compra Forte (10B / 2H / 0S)
Última Surpresa de Resultados:+2.16%

Métricas de Avaliação

Rácio P/E

28.11

ROE

15.4%

Rácio P/B

4.28

P/FCF

-

Margem Bruta

20.3%

ROIC

7.6%

Radar de Rentabilidade

Value Creation (Economic Moat)

ROIC

7.6%

WACC

6.8%

ROIC − WACC

+0.8 pp

ROIC is roughly in line with the cost of capital — the company is barely covering its capital cost.

Critérios de Análise Fundamental

Aprovado (17)

  • EPS shows upward trend
  • EPS CAGR 8.64%
  • Price CAGR 24.07%
  • ROIC 7.6%
  • Debt/Equity ratio
  • Operating Margin 8.6%
  • Current Ratio
  • Interest Coverage
  • Debt/EBITDA
  • Return on Tangible Assets
  • Low reliance on intangibles
  • ROE 16.5%
  • Revenue Growth 5Y 16.1%
  • Analyst Consensus 83% Buy
  • Earnings Quality (OCF/NI) 1.61
  • Share Dilution 1.2%
  • Piotroski F-Score 5/9

Reprovado (7)

  • Gross Margin 20.3%
  • P/B Ratio 4.28
  • Price below Graham Number
  • DCF valuation (Overvalued)
  • Earnings Surprise avg 0.7%
  • PEG Ratio 2.02
  • Net Margin Trend 6.9% vs 7.0%

Indisponível (4)

  • P/FCF NaN
  • Dividend Payout NaN%
  • Positive Free Cash Flow
  • CapEx intensity

Piotroski F-Score

5/9

Sinais mistos: algumas áreas requerem atenção

score
criteria

Qualidade dos Resultados

1.61

Alta qualidade: resultados respaldados por caixa

Diluição de Ações

1.2%

Número de ações estável

Governação

Equipa Executiva

NomeCargoIdade
Mr. Barry R. PortCEO & Chairman of the Board51
Mr. Spencer W. BurtonPresident & COO46
Ms. Suzanne D. Snapper CPACFO, Executive VP & Director51
Mr. Chad A. Keetch J.D.Chief Investment Officer, Executive VP & Secretary47
Ms. Beverly B. WittekindExecutive VP & General Counsel60
Kevin ReesePresident of Keystone Healthcare Inc-

Risco de Auditoria

7

Risco do Conselho

5

Risco de Remuneração

7

Risco dos Direitos dos Acionistas

2

Parte 2 · O preço e o momento de entrar

Esta parte não serve para saber se a empresa vale: serve para escolher quando comprá-la, depois que os fundamentos te convenceram. Dentro: análise técnica, potencial, quedas históricas, exposição gama.

Latest News

Recent headlines for ENSG, sourced from Markets Gazette.

No recent news for ENSG.